Celcuity Inc.
CELC
Price:
$15.11
Market Cap:
$559.53M
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative labora...[Read more]
Industry
Biotechnology
IPO Date
2017-09-20
Stock Exchange
NASDAQ
Ticker
CELC
The ROE as of September 2024 (TTM) for Celcuity Inc. (CELC) is -60.83%
According to Celcuity Inc.’s latest financial reports and current stock price. The company's current ROE is -60.83%. This represents a change of 286.92% compared to the average of -15.72% of the last 4 quarters.
Celcuity Inc. (CELC) Historical ROE (quarterly & annually)
How has CELC ROE performed in the past?
The mean historical ROE of Celcuity Inc. over the last ten years is -43.17%. The current -60.83% ROE has changed 40.89% with respect to the historical average. Over the past ten years (40 quarters), CELC's ROE was at its highest in in the June 2001 quarter at 0%. The ROE was at its lowest in in the June 2021 quarter at -51.91%.
Average
-43.17%
Median
-44.48%
Minimum
-77.67%
Maximum
-19.92%
Celcuity Inc. (CELC) ROE by Quarter and Year
Discovering the peaks and valleys of Celcuity Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 113.48%
Maximum Annual ROE = -19.92%
Minimum Annual Increase = -66.24%
Minimum Annual ROE = -77.67%
| Year | ROE | Change |
|---|---|---|
| 2023 | -45.63% | 47.63% |
| 2022 | -30.91% | -30.51% |
| 2021 | -44.48% | -42.73% |
| 2020 | -77.67% | 113.48% |
| 2019 | -36.38% | 23.28% |
| 2018 | -29.51% | 48.18% |
| 2017 | -19.92% | -66.24% |
| 2016 | -58.99% | 30.85% |
Celcuity Inc. (CELC) Average ROE
How has CELC ROE performed in the past?
The current ROE of Celcuity Inc. (CELC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-40.34%
5-year avg
-47.01%
10-year avg
-43.17%
Celcuity Inc. (CELC) ROE vs. Peers
How is CELC’s ROE compared to its peers?
Celcuity Inc.’s ROE is greater than Werewolf Therapeutics, Inc. (-48.25%), greater than Edgewise Therapeutics, Inc. (-28.01%), greater than Decibel Therapeutics, Inc. (-84.03%), greater than C4 Therapeutics, Inc. (-44.60%), greater than Anebulo Pharmaceuticals, Inc. (-122.97%), greater than Adagene Inc. (-63.48%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.31%), greater than AnaptysBio, Inc. (-255.67%), greater than Mineralys Therapeutics, Inc. (-42.61%), greater than Molecular Partners AG (-33.08%), greater than MediciNova, Inc. (-13.37%), less than Champions Oncology, Inc. (323.52%), greater than Cyteir Therapeutics, Inc. (-23.13%), greater than Ikena Oncology, Inc. (-42.81%), greater than Rezolute, Inc. (-60.90%), greater than Aerovate Therapeutics, Inc. (-83.65%), greater than AN2 Therapeutics, Inc. (-54.72%),
| Company | ROE | Market cap |
|---|---|---|
| -48.25% | $93.09M | |
| -28.01% | $1.57B | |
| -84.03% | $123.37M | |
| -44.60% | $440.29M | |
| -122.97% | $54.20M | |
| -63.48% | $123.96M | |
| -47.31% | $262.95M | |
| -255.67% | $1.16B | |
| -42.61% | $576.83M | |
| -33.08% | $172.94M | |
| -13.37% | $89.26M | |
| 323.52% | $69.90M | |
| -23.13% | $108.71M | |
| -42.81% | $83.00M | |
| -60.90% | $285.34M | |
| -83.65% | $55.43M | |
| -54.72% | $31.19M |
Build a custom stock screener for Celcuity Inc. (CELC) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celcuity Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Celcuity Inc. (CELC) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Celcuity Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Celcuity Inc.'s ROE?
How is the ROE calculated for Celcuity Inc. (CELC)?
What is the highest ROE for Celcuity Inc. (CELC)?
What is the 3-year average ROE for Celcuity Inc. (CELC)?
What is the 5-year average ROE for Celcuity Inc. (CELC)?
How does the current ROE for Celcuity Inc. (CELC) compare to its historical average?